Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Nobile

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Acta Haematologica|November 1, 2008
Twice-weekly high-dose rHuEpo for the treatment of anemia in patients with low-risk myelodysplastic syndromesR Latagliata, E N Oliva, P Volpicelli, et al.
Acta Haematologica|January 1, 1981
Ph1-negative T lymphocytic colonies in agar cultures of peripheral blood in chronic myeloid leukemiaG P Bagnara, G Biagini, M Marani, et al.
British Journal of Haematology|December 3, 1999
Surface CD14 positivity in B-cell chronic lymphocytic leukaemia is related to clinical outcomeV Callea, F Morabito, B M Oliva, et al.
European Journal of Haematology|September 10, 1999
Retrospective study of candidemia in patients with hematological malignancies. Clinical features, risk factors and outcome of 76 episodesL Pagano, A Antinori, A Ammassari, et al.
Bollettino Dell'Istituto Sieroterapico Milanese|January 1, 1980
T-colonies in agar culture: clonal proliferation of T-progenitors or PHA-transformation of mature T-lymphocytes?A Neri, G P Bagnara, G Biagini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
CD56 expression is an indicator of poor clinical outcome in patients with acute promyelocytic leukemia treated with simultaneous all-trans-retinoic acid and chemotherapyF Ferrara, F Morabito, B Martino, et al.
Leukemia|August 5, 2005
Gemtuzumab ozogamicin (Mylotarg) as single-agent treatment for frail patients 61 years of age and older with acute myeloid leukemia: final results of AML-15B, a phase 2 study of the European Organisation for Research and Treatment of Cancer and Gruppo Italiano Malattie Ematologiche dell'Adulto Leukemia GroupsS Amadori, S Suciu, R Stasi, et al.
Leukemia|September 1, 1996
Outcome of patients with acute myeloid leukemia who failed to respond to a single course of first-line induction therapy: a GIMEMA study of 218 unselected consecutive patients. Gruppo Italiano Malattie Ematologiche Maligne dell'AdultoV Liso, P Iacopino, G Avvisati, et al.
Leukemia|May 24, 2003
Treatment of elderly patients (> or =60 years) with newly diagnosed acute promyelocytic leukemia. Results of the Italian multicenter group GIMEMA with ATRA and idarubicin (AIDA) protocolsF Mandelli, R Latagliata, G Avvisati, et al.
Leukemia|August 26, 2006
Non-infusional vs intravenous consolidation chemotherapy in elderly patients with acute myeloid leukemia: final results of the EORTC-GIMEMA AML-13 randomized phase III trialU Jehn, S Suciu, X Thomas, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Acta Haematologica|November 1, 2008
Twice-weekly high-dose rHuEpo for the treatment of anemia in patients with low-risk myelodysplastic syndromesR Latagliata, E N Oliva, P Volpicelli, et al.
Acta Haematologica|January 1, 1981
Ph1-negative T lymphocytic colonies in agar cultures of peripheral blood in chronic myeloid leukemiaG P Bagnara, G Biagini, M Marani, et al.
British Journal of Haematology|December 3, 1999
Surface CD14 positivity in B-cell chronic lymphocytic leukaemia is related to clinical outcomeV Callea, F Morabito, B M Oliva, et al.
European Journal of Haematology|September 10, 1999
Retrospective study of candidemia in patients with hematological malignancies. Clinical features, risk factors and outcome of 76 episodesL Pagano, A Antinori, A Ammassari, et al.
Bollettino Dell'Istituto Sieroterapico Milanese|January 1, 1980
T-colonies in agar culture: clonal proliferation of T-progenitors or PHA-transformation of mature T-lymphocytes?A Neri, G P Bagnara, G Biagini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
CD56 expression is an indicator of poor clinical outcome in patients with acute promyelocytic leukemia treated with simultaneous all-trans-retinoic acid and chemotherapyF Ferrara, F Morabito, B Martino, et al.
Leukemia|August 5, 2005
Gemtuzumab ozogamicin (Mylotarg) as single-agent treatment for frail patients 61 years of age and older with acute myeloid leukemia: final results of AML-15B, a phase 2 study of the European Organisation for Research and Treatment of Cancer and Gruppo Italiano Malattie Ematologiche dell'Adulto Leukemia GroupsS Amadori, S Suciu, R Stasi, et al.
Leukemia|September 1, 1996
Outcome of patients with acute myeloid leukemia who failed to respond to a single course of first-line induction therapy: a GIMEMA study of 218 unselected consecutive patients. Gruppo Italiano Malattie Ematologiche Maligne dell'AdultoV Liso, P Iacopino, G Avvisati, et al.
Leukemia|May 24, 2003
Treatment of elderly patients (> or =60 years) with newly diagnosed acute promyelocytic leukemia. Results of the Italian multicenter group GIMEMA with ATRA and idarubicin (AIDA) protocolsF Mandelli, R Latagliata, G Avvisati, et al.
Leukemia|August 26, 2006
Non-infusional vs intravenous consolidation chemotherapy in elderly patients with acute myeloid leukemia: final results of the EORTC-GIMEMA AML-13 randomized phase III trialU Jehn, S Suciu, X Thomas, et al.
Pageof 5